Platelet monoamine oxidase activity and genetic vulnerability to schizophrenia

Am J Psychiatry. 1984 Jul;141(7):836-42. doi: 10.1176/ajp.141.7.836.

Abstract

Platelet monoamine oxidase (MAO) activity, determined in 102 patients with chronic schizophrenia, 223 first-degree relatives, and 88 normal control subjects, was shown to be a heritable and stable trait and was significantly lower in patients than in normal control subjects. Within families, MAO activity distinguished ill from well relatives. However, the considerable overlap in enzyme activity between affected and unaffected individuals limits the usefulness of low MAO activity as a major risk factor in schizophrenia.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Blood Platelets / enzymology*
  • Chronic Disease
  • Female
  • Humans
  • Male
  • Middle Aged
  • Monoamine Oxidase / metabolism*
  • Risk
  • Schizophrenia / enzymology
  • Schizophrenia / genetics*
  • Schizotypal Personality Disorder / enzymology
  • Schizotypal Personality Disorder / genetics
  • Sex Factors

Substances

  • Monoamine Oxidase